TRIM29 anticorps (AA 253-283)
Aperçu rapide pour TRIM29 anticorps (AA 253-283) (ABIN873066)
Antigène
Voir toutes TRIM29 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 253-283
-
Fonction
- TRIM29 Polyclonal Antibody
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human TRIM29/ATDC
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB(1:300-5000), IHC-P(1:200-400), IF(IHC-P)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- TRIM29 (Tripartite Motif Containing 29 (TRIM29))
-
Autre désignation
- Trim29
-
Sujet
-
Synonyms: ATDC, Tripartite motif-containing protein 29, Ataxia telangiectasia group D-associated protein, TRIM29
Background: It is able to complement the radiosensitivity defect of an ataxia telangiectasia (AT) fibroblast cell line.
-
ID gène
- 23650
-
UniProt
- Q14134
-
Pathways
- Signalisation p53, Apoptose, Réparation de l'ADN, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Antigène
-